Dow Up0.59% Nasdaq Up0.75%

Theravance Inc. (THRX)

-NasdaqGS
18.45 Down 0.01(0.05%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 4,758   135,758   24,512  
Cost of Revenue -   -   -  
Gross Profit 4,758   135,758   24,512  
Operating Expenses
Research Development125,181  117,898  103,568  
Selling General and Administrative48,440  30,859  30,681  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (168,863) (12,999) (109,737)
Income from Continuing Operations
Total Other Income/Expenses Net7,510  460  415  
Earnings Before Interest And Taxes(161,353)(12,539)(109,322)
Interest Expense9,348  6,003  6,022  
Income Before Tax(170,701)(18,542)(115,344)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(170,701)(18,542)(115,344)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (170,701) (18,542) (115,344)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (170,701) (18,542) (115,344)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.